Endothelial progenitor cells for vascular regeneration.
暂无分享,去创建一个
[1] A M Zeiher,et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. , 2001, The Journal of clinical investigation.
[2] J. Isner,et al. HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. , 2001, The Journal of clinical investigation.
[3] S. Fichtlscherer,et al. Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease , 2001, Circulation.
[4] T. Murohara,et al. Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001, Circulation.
[5] S. Homma,et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.
[6] J. Isner,et al. Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.
[7] S. Rafii,et al. Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells , 2001, Circulation research.
[8] I. Shiojima,et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. , 2000, Nature Medicine.
[9] J. Isner,et al. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. , 2000, The Annals of thoracic surgery.
[10] J. Isner,et al. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. , 2000, Circulation research.
[11] K. Pantel,et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells , 2000 .
[12] S. Dirnhofer,et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells , 2000, The Lancet.
[13] J. Isner,et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] S. Rafii,et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.
[15] J. Isner,et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.
[16] J. Isner,et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.
[17] J. Isner,et al. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. , 1999, Circulation.
[18] J. Garcia,et al. Human cord blood CD34+CD38- cell transduction via lentivirus-based gene transfer vectors. , 1999, Human gene therapy.
[19] Hiroshi Takahashi,et al. Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon , 1999, Nature Medicine.
[20] Haruchika Masuda,et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.
[21] J. Isner,et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. , 1999, The American journal of pathology.
[22] J. Isner,et al. Age-dependent impairment of angiogenesis. , 1999, Circulation.
[23] J. Isner,et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. , 1998, Journal of vascular surgery.
[24] R. Sidman,et al. Engraftable human neural stem cells respond to development cues, replace neurons, and express foreign genes , 1998, Nature Biotechnology.
[25] S. Rafii,et al. Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.
[26] J. Folkman,et al. Isolation and characterization of endothelial progenitor cells from mouse embryos. , 1998, Development.
[27] J. Isner,et al. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. , 1997, Circulation.
[28] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[29] M. Petch,et al. Aging-associated endothelial dysfunction in humans is reversed by L-arginine. , 1996, Journal of the American College of Cardiology.
[30] T. Lüscher,et al. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. , 1996, The Journal of clinical investigation.
[31] Kenneth J. Hillan,et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.
[32] Lieve Moons,et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.
[33] M. Creager,et al. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. , 1996, Hypertension.
[34] S. Heimfeld,et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. , 1995, The New England journal of medicine.
[35] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[36] L. Ghiadoni,et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. , 1995, Circulation.
[37] M. Creager,et al. Impaired Endothelium‐Dependent Vasodilation in Patients With Insulin‐Dependent Diabetes Mellitus , 1993, Circulation.
[38] W. Risau,et al. Induction of vasculogenesis and hematopoiesis in vitro. , 1992, Development.
[39] R. M. Fox,et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy , 1992, The Lancet.
[40] H. Drexler,et al. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine , 1991, The Lancet.
[41] J. Armitage,et al. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. , 1991, Blood.
[42] C D Marsden,et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. , 1990, Science.
[43] L. Pardanaud,et al. Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. , 1989, Development.
[44] T. Doetschman,et al. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. , 1988, Development.
[45] J. Glowacki,et al. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[47] J Folkman,et al. Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.
[48] R. Hebbel,et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.
[49] T. Lüscher,et al. Endothelial dysfunction in diabetes mellitus. , 1998, Journal of cardiovascular pharmacology.
[50] K. Rajewsky,et al. Perspectives Series: Molecular Medicine in Genetically Engineered Animals , 1996 .
[51] E. Shpall,et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] T. Lüscher,et al. Endothelial dysfunction in coronary artery disease. , 1993, Annual review of medicine.